Inogen (INGN) continues its turnaround, showing progress in revenue growth and margins, but the pace remains slower and riskier than the market desires. INGN posted positive adjusted EBITDA and raised ...

GOLETA, Calif. (AP) — GOLETA, Calif. (AP) — Inogen Inc. (INGN) on Wednesday reported a loss of $5.3 million in its third quarter. On a per-share basis, the Goleta, California-based company said it had ...

Needham analyst Mike Matson upgraded Inogen, Inc (NASDAQ:INGN) from Hold to Buy, with a price forecast of $12. On May 7, the company reported its first-quarter results. Total revenue in the quarter ...

Inogen’s financial position is also noted as strong, with a healthy current ratio of 3.07x and minimal debt-to-equity of 0.10. Get deeper insights into Inogen’s valuation and 8 additional key ProTips ...

Inogen, Inc. INGN recently announced a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (Yuwell), a global home healthcare medical device manufacturer with a ...

In 2024, Inogen introduced new products, including Rove 4, and received FDA clearance for the SIMEOX 200 device, expanding its global product offerings. The company maintains a strong financial ...

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management ...

Inogen INGN witnessed strong momentum in the year-to-date period. Shares of the company have surged 127.1% compared with 9.1% growth of the industry. The S&P 500 composite has risen 17.4% during the ...

Sandra Gordon is a journalist specializing in health and medicine for consumers and healthcare providers. Her work has appeared in major magazines and websites, including Prevention, Parents, Medical ...